SCN2A and epilepsy: Recently, SCN2A mutations have been implicated with epilepsy of infancy with migrating focal seizures (EIMFS) syndrome [16,17], benign familial neonatal infantile seizures (BFNIS) and early infantile epileptic encephalo-pathy (EIEE) [18].